Complement activation induces excessive T cell cytotoxicity in severe COVID-19 (2021)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.06.08.21258481
Publication URI: http://dx.doi.org/10.1101/2021.06.08.21258481
Type: Preprint